ACADIA Pharmaceuticals Inc.ACADNASDAQ
Loading
Gross Profit Over TimeExpanding
Percentile Rank100
3Y CAGR+24.7%
5Y CAGR+18.5%
Studio
Year-over-Year Change

Revenue minus cost of goods sold

3Y CAGR
+24.7%/yr
vs +25.3%/yr prior
5Y CAGR
+18.5%/yr
Recent acceleration
Acceleration
-0.7pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.3x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$982.51M+12.2%
2024$875.96M+28.7%
2023$680.71M+34.2%
2022$507.07M+9.0%
2021$465.00M+10.4%
2020$421.20M+31.8%
2019$319.48M+55.5%
2018$205.48M+83.7%
2017$111.84M+765.3%
2016$12.93M-